Naxesy 20 mg tvrde želučanootporne kapsule
| Name | Naxesy 20 mg tvrde želučanootporne kapsule |
|---|---|
| Marketing Authorisation Number | HR-H-588473124 |
| Active Substance | esomeprazolnatrij |
| Composition | svaka kapsula sadrži 20 mg esomeprazola (u obliku natrijeve soli) |
| Pharmaceutical Form | Želučanootporna kapsula, tvrda |
| Manufacturer | Lek Pharmaceuticals d.d., Ljubljana, Slovenija
Towa Pharmaceutical Europe S.L., Barcelona, Španjolska |
| Marketing Authorisation Holder | Sandoz d.o.o., Maksimirska 120, Zagreb, Hrvatska |
| Marketing Authorisation Date | 17.04.2025 |
| MA Period of Validity | 17.04.2030 |
| Classification Number | UP/I-530-09/24-01/227 |
| Registration Number | 381-12-01/286-25-06 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | ponovljivi recept |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | A02BC05 |
| Marketing status | nije stavljeno u promet |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
| Summary of risk management plan | download |
